Reply to T.A. Lin et al
- PMID: 37015028
- DOI: 10.1200/JCO.23.00482
Reply to T.A. Lin et al
Comment on
-
Determining the Efficacy of Pembrolizumab in Patients With Previously Treated Advanced Hepatocellular Carcinoma.J Clin Oncol. 2023 Jun 1;41(16):3074-3075. doi: 10.1200/JCO.23.00072. Epub 2023 Apr 4. J Clin Oncol. 2023. PMID: 37015029 Free PMC article. No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
